- Published at
- by manilatimes.net
positive
positive
News for GT Biopharma, Inc. (GTBP)
- Published at
- by gurufocus.com
positivepositiveGT Biopharma Announces Exercise of Warrants
SAN FRANCISCO, CALIFORNIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”Company”) ( GTBP), a clinical stage immuno-oncology company focused- Published at
- by rttnews.com
mixedmixed- Published at
- by gurufocus.com
positivepositiveGT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement
SAN FRANCISCO, CALIFORNIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”Company”) ( GTBP), a clinical stage immuno-oncology company focused- Published at
- by gurufocus.com
positivepositiveGT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies
Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”Company”) ( GT- Published at
- by investing.com
positivepositiveGTBP Stock Hits 52-Week Low at $1.92 Amid Market Challenges By Investing.com
GTBP Stock Hits 52-Week Low at $1.92 Amid Market Challenges- Published at
- by investing.com
positivepositiveGT Biopharma Reports Third Quarter 2024 Financial Results By Investing.com
GT Biopharma Reports Third Quarter 2024 Financial Results- Published at
- by globenewswire.com
positivepositiveGT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
SAN FRANCISCO, CALIFORNIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company...- Published at
- by investing.com
positivepositiveGT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024 By Investing.com
GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024- Published at
- by investing.com
neutralneutralGTBP stock touches 52-week low at $1.92 amid market challenges By Investing.com
GTBP stock touches 52-week low at $1.92 amid market challenges- Published at
- by globenewswire.com
positivepositiveGT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GTB-3650 TriKE® Phase 1 trial initiation expected in 2H 2024; initial clinical data expected in 1H 2025GTB-5550 TriKE® IND submission for treatment of B7H3...- Published at
- by investing.com
neutralneutralGTBP stock touches 52-week low at $2.52 amid market challenges By Investing.com
GTBP stock touches 52-week low at $2.52 amid market challenges- Published at
- by globenewswire.com
neutralneutralGT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025GTB-5550 TriKE® IND submission for treatment of B7H3...- Published at
- by investing.com
neutralneutralGT Biopharma announces $3.2 million stock offering By Investing.com
GT Biopharma announces $3.2 million stock offering- Published at
- by benzinga.com
mixedmixedWhy Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Virios Therapeutics (NASDAQ:VIRI)
Loading... Loading... Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of ...- Published at
- by benzinga.com
mixedmixedWhy Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Wix.com (NASDAQ:WIX)
Loading... Loading... Shares of Wix.com Ltd. WIX rose sharply in today's pre-market trading as the company posted upbeat results for its first quarter and rais...- Published at
- by benzinga.com
mixedmixedWhy Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday’s Mid-Day Session - Cutera (NASDAQ:CUTR)
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.YTENWEED.TOOTLKOCGN.MXOCGNNVFYNKTXNKED.BANKECL.SNNKE.SNNKE.MXNKE.DENKE.BANKEKCK2CG34.SAJOANIMACWIMACIDNGTBPFRSX.TAFRSXFDXB34.SAFDX.MXFDX.DEFDXCUTRCGCBYND.CNBIOLANNXAMTX0QZX.LSMLPSINTRETOLICYCZOO0A8S.LMWK.MXMWKLXEHLULU.MXLULUL1UL34.SAGRFSGRFPN.MXGRF.MCGIKLYGIFOFGIFLFFOOTL.BRFLATER.MXATERAIR33L.DE0JVT.L0IQK.L- Published at
- by benzinga.com
mixedmixedWhy Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Aehr Test Systems (NASDAQ:AEHR), ACADIA Pharmaceuticals (NASDAQ:ACAD)
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.- Published at
- by marketscreener.com
mixedmixedGT Biopharma : Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer
BEVERLY HILLS, Calif., Aug. 23, 2021 /PRNewswire/ -- GT Biopharma, Inc. , a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's... | August 23, 2021- Published at
- by markets.businessinsider.com
mixedmixedThe Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au...ZIVOPFED.BAPFECL.SNPFE.MXPFE.DEPFEMDNA.TOMDNAJAZZHARPFUSNCODXCAPRBNTXN.MXBNTX0A50.L0A3M.LZLDPFZIOPZGNXZEALXCURVYNEVYGR.MXVYGRVECTTXMDTRVNTRIL.TOTRILTLGTTFFPTARASPRBSONNRVMDRPIDRMTIPROGPRAXPMCBDPMCBPBLAPASGORTXNKTRNBIXMRNA.MXMRNAMNOVMBRXM1RN34.SALVTXLUMOLMNLKRONKPTIKNSAJAGXITRMIRWDIRTCINCYINABIMRAIKTI1NC34.SAHRTXHOTHHOOKHBIOGTBPGRFSGRFPN.MXGRF.MCGIS.DEGILDD.BAGILD.MXGILDGIKLYGIFOFGIFLFFMTXFLXNFGEN.MXFGENEYEGEWTXEPZMENSCWENSCDVAXDRNADMACCTMXCLRBCELUBXRXBUWA.DEBPTHBMEABIOLBIO-BBIOBDSXBAX.MXBAXAYTUAXSMATAIARDSALLOALKSALIMAKROAGLEACHLACAD4875.T0UNL.L0QK8.L0M3O.L0K6R.L0J9P.L0J4V.L0IL8.L0IDA.L0HKF.L0A8M.L0A7L.L0A4W.L0A45.LSESNJNJINVADJNJ3.BADJNJ2.BAARNAAPREABVC0S54.L